To include your compound in the COVID-19 Resource Center, submit it here.

Adcetris brentuximab vedotin regulatory update

The European Commission approved an expanded label for Adcetris brentuximab vedotin from Takeda to include

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE